Biodesix (BDSX) Competitors $1.57 +0.21 (+15.44%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BDSX vs. FLGT, INNV, AUNA, CELC, DCGO, EHAB, AIRS, VMD, SERA, and PSNLShould you be buying Biodesix stock or one of its competitors? The main competitors of Biodesix include Fulgent Genetics (FLGT), InnovAge (INNV), Auna (AUNA), Celcuity (CELC), DocGo (DCGO), Enhabit (EHAB), AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Sera Prognostics (SERA), and Personalis (PSNL). These companies are all part of the "healthcare" industry. Biodesix vs. Fulgent Genetics InnovAge Auna Celcuity DocGo Enhabit AirSculpt Technologies Viemed Healthcare Sera Prognostics Personalis Fulgent Genetics (NASDAQ:FLGT) and Biodesix (NASDAQ:BDSX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment. Which has more risk and volatility, FLGT or BDSX? Fulgent Genetics has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, Biodesix has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Does the media prefer FLGT or BDSX? In the previous week, Fulgent Genetics had 3 more articles in the media than Biodesix. MarketBeat recorded 3 mentions for Fulgent Genetics and 0 mentions for Biodesix. Fulgent Genetics' average media sentiment score of 1.03 beat Biodesix's score of 0.00 indicating that Fulgent Genetics is being referred to more favorably in the media. Company Overall Sentiment Fulgent Genetics Positive Biodesix Neutral Is FLGT or BDSX more profitable? Fulgent Genetics has a net margin of -59.39% compared to Biodesix's net margin of -66.84%. Fulgent Genetics' return on equity of -1.81% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Fulgent Genetics-59.39% -1.81% -1.66% Biodesix -66.84%-275.79%-43.05% Which has stronger valuation & earnings, FLGT or BDSX? Biodesix has lower revenue, but higher earnings than Fulgent Genetics. Biodesix is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFulgent Genetics$277.76M2.02-$167.82M-$5.52-3.32Biodesix$65.56M3.48-$52.15M-$0.39-4.03 Do analysts prefer FLGT or BDSX? Fulgent Genetics presently has a consensus price target of $22.00, indicating a potential upside of 19.96%. Biodesix has a consensus price target of $3.06, indicating a potential upside of 94.90%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Biodesix 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in FLGT or BDSX? 48.1% of Fulgent Genetics shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 31.8% of Fulgent Genetics shares are owned by company insiders. Comparatively, 69.2% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in FLGT or BDSX? Fulgent Genetics received 215 more outperform votes than Biodesix when rated by MarketBeat users. However, 74.36% of users gave Biodesix an outperform vote while only 60.10% of users gave Fulgent Genetics an outperform vote. CompanyUnderperformOutperformFulgent GeneticsOutperform Votes24460.10% Underperform Votes16239.90% BiodesixOutperform Votes2974.36% Underperform Votes1025.64% SummaryFulgent Genetics beats Biodesix on 10 of the 18 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDSX vs. The Competition Export to ExcelMetricBiodesixMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$228.38M$2.93B$5.13B$9.07BDividend YieldN/A15.63%5.08%4.23%P/E Ratio-4.0316.0289.5817.17Price / Sales3.48284.461,116.12116.95Price / CashN/A472.1142.8237.86Price / Book31.405.194.774.78Net Income-$52.15M-$32.86M$120.15M$225.60M7 Day Performance17.16%-3.01%-1.92%-1.23%1 Month Performance30.83%2.96%11.47%3.36%1 Year Performance-4.85%12.37%30.54%16.60% Biodesix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDSXBiodesix2.5565 of 5 stars$1.57+15.4%$3.06+94.9%-4.8%$228.38M$65.56M-4.03220High Trading VolumeFLGTFulgent Genetics3.7083 of 5 stars$19.85+1.4%$22.00+10.8%-35.9%$607.15M$277.76M-3.551,184News CoveragePositive NewsINNVInnovAge1.2858 of 5 stars$4.45+0.2%$6.50+46.1%-25.4%$602.78M$786.51M-37.002,350Analyst ForecastNews CoverageAUNAAuna3.2169 of 5 stars$6.69+2.8%$13.40+100.3%N/A$494.51M$4.34B0.0014,958News CoverageCELCCelcuity2.6129 of 5 stars$12.26-2.1%$29.17+137.9%-13.6%$455.21MN/A-4.8040News CoverageHigh Trading VolumeDCGODocGo2.5881 of 5 stars$4.42+3.0%$6.10+38.0%-15.2%$451.07M$694.97M15.324,164Gap DownEHABEnhabit2.7687 of 5 stars$8.56+0.5%$8.75+2.2%-27.4%$430.43M$1.04B-3.6710,800AIRSAirSculpt Technologies0.3584 of 5 stars$6.01+5.8%$5.00-16.8%-26.3%$347.87M$188.78M-43.71346Positive NewsVMDViemed Healthcare1.7209 of 5 stars$8.67-0.8%N/A+3.6%$337.61M$183.01M32.37630Positive NewsSERASera Prognostics0.2236 of 5 stars$8.42-2.3%N/A+28.2%$284.34M$310,000.00-8.71120News CoveragePSNLPersonalis3.9711 of 5 stars$3.81-0.3%$6.81+78.8%+293.8%$269.18M$73.48M-2.27400Analyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies FLGT Competitors INNV Competitors AUNA Competitors CELC Competitors DCGO Competitors EHAB Competitors AIRS Competitors VMD Competitors SERA Competitors PSNL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BDSX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
